Full Papers
Improvement of microangiopathy after haematopoietic stem cell transplantation in systemic sclerosis
M. Boonstra1, J. Ciaffi2, D.C. Noordhoek3, S.I. Liem4, L.J. Beaart-Van de voorde5, S.T. Van Bijnen6, T.W. Huizinga7, M.C. Vonk8, J.K. De vries-Bouwstra9
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
- Medicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy. jacopo.ciaffi91@gmail.com
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Rheumatology, Radboudumc, Nijmegen, The Netherlands.
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Rheumatology, Radboudumc, Nijmegen, The Netherlands.
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
CER16050
2022 Vol.40, N°10
PI 1993, PF 1998
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 36259604 [PubMed]
Received: 13/07/2022
Accepted : 10/10/2022
In Press: 17/10/2022
Published: 17/10/2022
Abstract
OBJECTIVES:
Haematopoietic stem cell transplantation (HSCT) is a treatment option for patients with severe systemic sclerosis (SSc), but the efficacy of the procedure in remodelling the nailfold microvascular array is largely unknown. Therefore, this study aimed to evaluate the effect of HSCT on microangiopathy assessed through nailfold capillaroscopy (NC) and to compare the results with findings in patients receiving conventional immunosuppression.
METHODS:
We included SSc patients with severe SSc and whose pre- and post-treatment NC images were available. Findings in patients treated with HSCT were compared with patients not treated with HSCT. Images were scored by two independent observers blinded for clinical data and treatment history. Capillary pattern was determined and semiquantitative scores from 0 (no changes) to 3 (>66% alterations per millimetre) were used to quantify the degree of specific microvascular characteristics. Changes in severity of microangiopathy between baseline and post-treatment were compared between groups.
RESULTS:
Images of 18 HSCT patients and 21 controls were scored. From baseline to follow-up, 33% of HSCT patients showed improvement from scleroderma pattern to normal NC, compared to 6% of controls (p=0.15). Pre- to post-treatment differences in semiquantitative scores showed significant improvement in HSCT patients compared to controls regarding capillary loss (-0.5 vs. 0.0, p<0.05) and disorganisation (-0.8 vs. 0.0, p<0.05).
CONCLUSIONS:
The degree of microangiopathy improved significantly in severe SSc patients treated with HSCT compared with patients receiving conventional immunosuppressive therapy.
